If you need more lookups,
subscriptions start at $34 USD/month.
Kevin Marks Location
Cambridge, MA, US
Kevin Marks Work
2024 -now President and CEO @
2024 -now Advisor @
2022 -2024 co-founder and President @
2022 -2024 Entrepreneur in Residence @
2020 -2022 Head, Oncology Drug Discovery, Cambridge @
2018 -2020 Vice President of Biology @
2016 -2018 Sr. Director and Head of Cancer Biology @
2014 -2016 Director, Biology @
2011 -2014 Associate Director, Cell Metabolism @
2009 -2011 Senior Scientist, Cell Metabolism @
2006 -2009 Sr. Scientist @
2004 -2006 Scientist @
Kevin Marks Education
Stanford University
PhD, Molecular Pharmacology/Chemical & Systems Biology (Molecular Pharmacology/Chemical & Systems Biology)
1998-2003
Cornell University
BA, Biology (Biology)
1995-1998
Kevin Marks Skills
Biochemistry
Microsoft Excel
Biotechnology
Cell Culture
Molecular Biology
Musikbranche
B2G
Kevin Marks Summary
Kevin Marks, based in Cambridge, MA, US, is currently a President and CEO at Delphia Therapeutics. Kevin Marks brings experience from previous roles at GV, Delphia Therapeutics and Novartis Institutes for BioMedical Research (NIBR). Kevin Marks holds a 1998 - 2003 PhD, Molecular Pharmacology/Chemical & Systems Biology in Molecular Pharmacology/Chemical & Systems Biology @ Stanford University. With a robust skill set that includes Biochemistry, Microsoft Excel, Biotechnology, Cell Culture, Molecular Biology and more. Kevin Marks has 7 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kevin Marks?
Find contact details for 700 million professionals.